1. Home
  2. CIRC vs CYPH Comparison

CIRC vs CYPH Comparison

Compare CIRC & CYPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CIRC

Circle8 Group Inc. Common Stock

N/A

Current Price

$0.79

Market Cap

67.3M

Sector

N/A

ML Signal

N/A

CYPH

Cypherpunk Technologies Inc.

HOLD

Current Price

$0.62

Market Cap

73.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CIRC
CYPH
Founded
N/A
2011
Country
United States
United States
Employees
N/A
6
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
67.3M
73.4M
IPO Year
2024
N/A

Fundamental Metrics

Financial Performance
Metric
CIRC
CYPH
Price
$0.79
$0.62
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
8.1M
1.6M
Earning Date
N/A
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.55
$0.49
52 Week High
$0.98
$3.70

Technical Indicators

Market Signals
Indicator
CIRC
CYPH
Relative Strength Index (RSI) 52.09 39.64
Support Level $0.63 $0.58
Resistance Level $0.82 $0.80
Average True Range (ATR) 0.12 0.06
MACD 0.00 0.00
Stochastic Oscillator 53.43 2.88

Price Performance

Historical Comparison
CIRC
CYPH

About CYPH Cypherpunk Technologies Inc.

Cypherpunk Technologies Inc is a privacy technology company focused on implementing a digital asset treasury business anchored by Zcash, which is a cryptographic digital asset that operates on a decentralized, open-source blockchain network known as the Zcash Network. Through its subsidiary, the company is also engaged in developing novel therapies for patients with cancer. The group holds Zcash as part of its digital treasury business and has the following drug candidates under development in its biopharma business: Sirexatamab (DKN-01), a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1; and a preclinical antibody program, FL-501, that is designed to treat cachexia-related indications.

Share on Social Networks: